LogicBio guns for $75M IPO; Alexandria lands a new biotech building on Long Island
→ Prolific life-science developer Alexandria Real Estate Equities just plopped down $75M for a building in Long Island City fresh off the heels of its purchase of Pfizer HQ in Manhattan earlier this year.
→ Cambridge-based LogicBio is aiming for a $75 million haul during its IPO run. The gene editing company is looking to beef up its coffers for a Phase I/II run on methylmalonic acidemia (MMA). It will list under $LOGC on Nasdaq.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.